Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer.
Lin HM, Huynh K, Kohli M, Tan W, Azad AA, Yeung N, Mahon KL, Mak B, Sutherland PD, Shepherd A, Mellett N, Docanto M, Giles C, Centenera MM, Butler LM, Meikle PJ, Horvath LG.
Lin HM, et al. Among authors: meikle pj.
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):860-870. doi: 10.1038/s41391-021-00338-z. Epub 2021 Mar 21.
Prostate Cancer Prostatic Dis. 2021.
PMID: 33746214
Free PMC article.